The RNA total isolation system LeukoLOCK™ is an innovative method for cell fractionation of total blood and stabilization and extraction of total RNA from the leukocyte population. The kit is composed of a kit of...
The RNA total isolation system LeukoLOCK™ is an innovative method for cell fractionation of total blood and stabilization and extraction of total RNA from the leukocyte population. The kit consists of a LeukoLOCK stabilization and fractionation kit (also available separately; Cat. No. AM1933) and a total LeukoLOCK isolation kit.
LeukoLOCK is optimized for use with human blood. Blood is a cellular information storage device; however, the presence of globin mRNA in the RNA prepared from whole blood may interfere with downstream expression profiling applications. The LeukoLOCK system uses filter-based leukocyte depletion technology to isolate leukocytes from total blood and RNAlater™ solution to stabilize cells on the filter. By excluding red blood cells, the purified RNA from the captured leukocytes is intrinsically depleted to globin mRNA, which improves the usefulness of samples for expression profiling and other applications.
Leukocyte capture and stabilization
A 9-10 ml sample of anti-coagulated blood passes through a LeukoLOCK filter, which captures the total leukocyte population while eliminating red blood cells (including reticulocytes), platelets and plasma. After rinsing with phosphate buffered saline, the filter is rinsed with RNAlater to stabilize the RNA in the captured leukocytes. The RNA can be isolated immediately or stabilized cells can be maintained for several days at room temperature or for longer periods at –20°C or –80°C.
Purification of the RNA is performed by first disrupting cells captured in a guanidinium dethiocyanate solution that releases the RNA while simultaneously inactivating the nucleases. Cell lysate is taken and treated briefly with K proteinase. The RNA is then purified from lysate using MagMAX magnetic microbead technology for washing, followed by DNase treatment (with DNase TURBO™) and final cleaning.
Biochip and quantitative RT-PCR expression studies have validated the relevance of purified l的RNA for reliable profiling of transcriptomas. Compared to the RNA treated with a commonly used blood isolation procedure of RNA, the RNA isolated with the LeukoLOCK system produces a longer median aRNA after amplification and a higher percentage of calls present without requiring further post-extraction steps to eliminate the mRNA of globin. Since globin aRNA accounts for 25-40% of the peak of aRNA from total blood, the yield of total RNA is naturally lower with methods that exhaust undesirable globin transcripts. The RNA amplified after LeukoLOCK purification provides a greater sensitivity of the matrix due to the dramatic reduction of competing globin transcripts.
Recovery varies from donor to donor, but is generally 10-20 μg d的RNA per 9-10 ml of total blood. The recovery of the LeukoLOCK-derived L-RNA contains less than one tenth of the amount of alpha and beta globin derived from reticulocytes present in typical d-RNA samples from unfractionated total blood.
Not high-throughput compatible (manual)
Purification and analysis of DNA and RNA, extraction of RNA, isolation of total RNA, total RNA of animal cells and tissues, total RNA of blood
Fraction the leukocytes of the whole blood in...
Fraction the leukocytes of the whole blood within minutes
Total leukocyte extract
Total leukocyte extract
No further step of reducing...
No further globin reduction step is required
Stabilizes the RNA to preserve the profile...
Stabilizes the RNA to preserve the expression profile.
Keep leukocytes at room temperature...
Keep leukocytes at room temperature for several days.
Technical specifications
| General |
| Brand | Invitrogen |
| Supplier ref. (Fisher Scientific) | 10506945 |
| Specifications |
| Isolation Technology | Leukocyte capture filter, Magnetic microbead |
| Type of sample | Cells, blood |
| End product type | Total RNA |
| High-throughput compatibility | Not high-throughput compatible (manual) |
| For use with (application) | Biochip analysis, real-time quantitative PCR (qPCR), reverse transcriptase PCR (RT-PCR), nuclease protection assays, Northern transfer, library construction d |
| No. of reactions | 20 preparations |
| Preparation scale | > 1 ml blood samples (large scale) |
| Product range | Ambion™, LeukoLOCK™ |
| Quantity | 20 preps |
| Quantity of start-up equipment | Up to 10 ml of total blood |
| Target | Total RNA |
| Storage and shipping |
| Content and storage | Keep PBS 1X pH 7.4, RNA solutionlater;TM, rubber septum cap, white slip connector, transfer tip, LeukoLOCK™ filter, elution solution, LeukoLOCK™ ⁄ lysis binding solution, LeukoLOCK™ pH adjustment solution, milking tubes |
Origin and customs
| Manufacturer ref. | AM1923 |
|---|
| Country of origin | United States |
|---|
| HS customs code | 3822 90 00 00 |
|---|
A question or a specific configuration?
Contact us for a quote.